• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

希腊人群中药物代谢酶CYP2D6、CYP2C9、CYP2C19和CYP3A5的基因多态性

Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population.

作者信息

Arvanitidis Kostas, Ragia Georgia, Iordanidou Maria, Kyriaki Sofia, Xanthi Athanasia, Tavridou Anna, Manolopoulos Vangelis G

机构信息

Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.

出版信息

Fundam Clin Pharmacol. 2007 Aug;21(4):419-26. doi: 10.1111/j.1472-8206.2007.00510.x.

DOI:10.1111/j.1472-8206.2007.00510.x
PMID:17635181
Abstract

The aim of the present study was to determine the prevalence of the most common allelic variants of the polymorphic cytochrome P450 (CYP) enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 and to predict the genotype frequency for each polymorphism in the Greek population. DNA isolated from peripheral blood samples derived from 283 non-related Greek ethnic subjects was used to determine the frequency of CYP2D63, CYP2D64, CYP2C92, CYP2C93 and CYP3A53 allelic variants by the polymerase chain reaction (PCR)-restriction fragment length polymorphism method, CYP2C192 and CYP2C193 with allelic specific amplification (PCR-ASA), and CYP2D62 (gene duplications) by long PCR analysis. The allelic frequencies (out of a total of 566 alleles) for CYP2D63 and CYP2D64, were 2.3% and 17.8%, respectively, while gene duplications (CYP2D62) were found in 7.4% of the subjects tested. For CYP2C92 and CYP2C93 polymorphisms the allelic frequencies were 12.9% and 8.13% respectively. For CYP2C19, the 2 polymorphism was present at an allelic frequency of 13.1%, while no subjects were found carrying the CYP2C193 allele. Finally, the CYP3A53 allele was abundantly present in the Greek population with an allelic frequency of 94.4%. Overall our results show that the frequencies of the common defective allelic variants of CYP2C9, CYP2C19 and CYP3A5 in Greek subjects are similar to those reported for several other Caucasian populations. Finally, a high prevalence of CYP2D6 gene duplication among Greeks was found, a finding that strengthens the idea that a South/North gradient exists in the occurrence of CYP2D6 ultrarapid metabolizers in European populations.

摘要

本研究的目的是确定多态性细胞色素P450(CYP)酶CYP2D6、CYP2C9、CYP2C19和CYP3A5最常见等位基因变体的流行情况,并预测希腊人群中每种多态性的基因型频率。从283名无亲缘关系的希腊族裔受试者的外周血样本中分离出的DNA,用于通过聚合酶链反应(PCR)-限制性片段长度多态性方法确定CYP2D63、CYP2D64、CYP2C92、CYP2C93和CYP3A53等位基因变体的频率,通过等位基因特异性扩增(PCR-ASA)确定CYP2C192和CYP2C193,通过长PCR分析确定CYP2D62(基因重复)。CYP2D63和CYP2D64的等位基因频率(在总共566个等位基因中)分别为2.3%和17.8%,而在7.4%的受试对象中发现了基因重复(CYP2D62)。对于CYP2C92和CYP2C93多态性,等位基因频率分别为12.9%和8.13%。对于CYP2C19,2多态性的等位基因频率为13.1%,而未发现携带CYP2C193等位基因的受试者。最后,CYP3A53等位基因在希腊人群中大量存在,等位基因频率为94.4%。总体而言,我们的结果表明,希腊受试者中CYP2C9、CYP2C19和CYP3A5常见缺陷等位基因变体的频率与其他几个白种人群体报告的频率相似。最后,发现希腊人中CYP2D6基因重复的发生率很高,这一发现强化了欧洲人群中CYP2D6超快代谢者的出现存在南/北梯度的观点。

相似文献

1
Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population.希腊人群中药物代谢酶CYP2D6、CYP2C9、CYP2C19和CYP3A5的基因多态性
Fundam Clin Pharmacol. 2007 Aug;21(4):419-26. doi: 10.1111/j.1472-8206.2007.00510.x.
2
Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population.克罗地亚人群中细胞色素P450的基因多态性:CYP2C9、CYP2C19和CYP2D6
Croat Med J. 2003 Aug;44(4):425-8.
3
Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.意大利人群中CYP2C9、CYP2C19和CYP2D6的等位基因及基因型频率
Pharmacol Res. 2004 Aug;50(2):195-200. doi: 10.1016/j.phrs.2004.01.004.
4
Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.俄罗斯人群中药物代谢酶CYP2C9、CYP2C19、CYP2D6、CYP1A1、NAT2及P-糖蛋白的多态性
Eur J Clin Pharmacol. 2003 Aug;59(4):303-12. doi: 10.1007/s00228-003-0606-2. Epub 2003 Jul 15.
5
Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population.法罗群岛人群中CYP2D6、CYP2C19、CYP2C9和CYP2C8的多态性
Eur J Clin Pharmacol. 2005 Aug;61(7):491-7. doi: 10.1007/s00228-005-0938-1. Epub 2005 Jul 16.
6
Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.约旦人群中多态细胞色素 P450 基因(CYP1A1、CYP3A4、CYP3A5、CYP2C9 和 CYP2C19)的等位基因和基因型频率。
Mol Biol Rep. 2012 Oct;39(10):9423-33. doi: 10.1007/s11033-012-1807-5. Epub 2012 Jun 22.
7
CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.阿什肯纳兹犹太人群体中CYP2C9、CYP2C19和CYP2D6等位基因频率
Pharmacogenomics. 2007 Jul;8(7):721-30. doi: 10.2217/14622416.8.7.721.
8
Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population.土耳其人群中细胞色素P450酶2C19和2D6缺陷等位基因的低频率
Clin Pharmacol Ther. 1999 Aug;66(2):185-92. doi: 10.1053/cp.1999.v66.100072001.
9
Pharmacogenetic relevant polymorphisms of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 in Bhutanese population.不丹人群中CYP2C9、CYP2C19、CYP2D6和CYP3A5的药物遗传学相关多态性
Drug Metab Pers Ther. 2019 Dec 18;34(4). doi: 10.1515/dmpt-2019-0020.
10
The high prevalence of the poor and ultrarapid metabolite alleles of CYP2D6, CYP2C9, CYP2C19, CYP3A4, and CYP3A5 in Taiwanese population.台湾人群中CYP2D6、CYP2C9、CYP2C19、CYP3A4和CYP3A5的低代谢和超快代谢等位基因的高流行率。
J Hum Genet. 2006;51(10):857. doi: 10.1007/s10038-006-0034-0. Epub 2006 Aug 19.

引用本文的文献

1
Genetic diversity of cytochrome P450 in patients receiving psychiatric care in Greece: a step towards clinical implementation.希腊接受精神科治疗患者细胞色素 P450 的遗传多样性:迈向临床实施的一步。
Pharmacogenomics. 2024;25(5-6):217-229. doi: 10.1080/14622416.2024.2346072. Epub 2024 May 14.
2
Genetic polymorphisms of CYP2C19 in ecuadorian population: An interethnic approach.厄瓜多尔人群中CYP2C19的基因多态性:一种跨种族研究方法。
Heliyon. 2024 Mar 27;10(7):e28566. doi: 10.1016/j.heliyon.2024.e28566. eCollection 2024 Apr 15.
3
Equivalence Trial of the Non-Bismuth 10-Day Concomitant and 14-Day Hybrid Therapies for Eradication in High Clarithromycin Resistance Areas.
在高克拉霉素耐药地区,非铋剂10天联合疗法与14天混合疗法根除幽门螺杆菌的等效性试验
Antibiotics (Basel). 2024 Mar 20;13(3):280. doi: 10.3390/antibiotics13030280.
4
*2/*2 Genotype is a Risk Factor for Multi-Site Arteriosclerosis: A Hospital-Based Cohort Study.2/2基因型是多部位动脉硬化的危险因素:一项基于医院的队列研究。
Int J Gen Med. 2023 Nov 6;16:5139-5146. doi: 10.2147/IJGM.S437251. eCollection 2023.
5
Differences in the Proportion of CYP2C19 Loss-of-Function Between Cerebral Infarction and Coronary Artery Disease Patients.脑梗死患者与冠状动脉疾病患者中CYP2C19功能丧失比例的差异。
Int J Gen Med. 2023 Aug 14;16:3473-3481. doi: 10.2147/IJGM.S420108. eCollection 2023.
6
Effects of Genetic Polymorphisms of Drug Metabolizing Enzymes and co-Medications on Tamoxifen Metabolism in Black South African Women with Breast Cancer.遗传药物代谢酶多态性和合并用药对南非黑人乳腺癌女性中他莫昔芬代谢的影响。
Clin Pharmacol Ther. 2023 Jul;114(1):127-136. doi: 10.1002/cpt.2904. Epub 2023 Apr 28.
7
CYP2C19 loss-of-function is associated with increased risk of hypertension in a Hakka population: a case-control study.CYP2C19 功能丧失与客家人群高血压风险增加相关:一项病例对照研究。
BMC Cardiovasc Disord. 2023 Apr 6;23(1):185. doi: 10.1186/s12872-023-03207-w.
8
Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect.遗传多态性在药物代谢酶介导的毒性和抗癌药物药代动力学耐药中的作用:药物基因组学方面的综述。
Clin Pharmacokinet. 2022 Nov;61(11):1495-1517. doi: 10.1007/s40262-022-01174-7. Epub 2022 Sep 30.
9
Ethnicity-based classifications and medical genetics: One Health approaches from a Western Pacific perspective.基于种族的分类与医学遗传学:西太平洋视角下的“同一健康”方法
Front Genet. 2022 Sep 6;13:970549. doi: 10.3389/fgene.2022.970549. eCollection 2022.
10
Prevalence of five pharmacologically most important and allelic variants in the population from the Republic of Srpska in Bosnia and Herzegovina.波黑塞族共和国人群中五种药理学上最重要的等位基因变体的流行情况。
Arh Hig Rada Toksikol. 2021 Jun 28;72(3):129-134. doi: 10.2478/aiht-2021-72-3499.